Lumoptik BRIGHTPOINT Reflectometer Device for Lumbar Epidural Placement
Hospital for Special Surgery, New York · NCT06020508
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–99 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 36
- US sites recruiting
- 1
- Study start
- September 12, 2023
- Record last updated
- August 10, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to test the BrightPoint Epidural device as the first system to use multispectral reflectometry to find the epidural space in lumbar neuraxial procedures requiring epidural needle. The main questions it aims to answer are:
- Is the device a qualitatively effective secondary confirmation of Loss of Resistance?
- Is the device a qualitatively effective training tool for educating trainees in how to perform lumbar epidurals?
Participants will undergo a neuraxial procedure in which the attending anesthesiologist will use the BrightPoint epidural device to form an opinion on its effectiveness in confirming epidural space access.
Being studied: Group 1 - Lumoptik BrightPoint Epidural Device
Conditions: Lumbar Spine Surgery
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Any patient undergoing a lumbar neuraxial procedure requiring epidural needle
- Age 18-99
Exclusion Criteria
- Previous lumbar spine surgery
- Any known spinal abnormality that would interfere with successfully advancing a needle into the epidural space
- Any patient requiring epidural needle longer than 4 inches
- Any contraindication to neuraxial anesthesia
- Tattoo at the site of epidural insertion
Recruiting US locations
Hospital for Special Surgery
New York, NY 10021
Site contact: Justas Lauzadis, PhD · 212-774-2946 · lauzadisj@hss.edu
Study contacts (from the official record)
- Pa Thor, PhD · 646-797-8535 · thorp@hss.edu
- Maya Tailor · 646-714-6828 · tailorm@hss.edu
Similar studies in New York
All healthy volunteers studies in New York →- RecruitingHealthy volunteers
Using Middle School Science Teachers to Address Cancer Health Disparities
Weill Medical College of Cornell University
- Location
- New York, NY + 1 other US site
- Eligibility basics
- Ages 10+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- New York, NY + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Staten Island, NY + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- East Syracuse, NY + 14 other US sites
- Eligibility basics
- Ages 2 mo–1